Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

NFE2L3 antibody (C-Term)

The Rabbit Polyclonal anti-NFE2L3 antibody has been validated for WB. It is suitable to detect NFE2L3 in samples from Human. There are 3+ publications available.
Catalog No. ABIN1881578

Quick Overview for NFE2L3 antibody (C-Term) (ABIN1881578)

Target

See all NFE2L3 Antibodies
NFE2L3 (Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3))

Reactivity

  • 24
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 25
Rabbit

Clonality

  • 25
Polyclonal

Conjugate

  • 10
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This NFE2L3 antibody is un-conjugated

Application

  • 15
  • 13
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB41576
  • Binding Specificity

    • 7
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 666-694, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This NFE2L3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 666-694 amino acids from the C-terminal region of human NFE2L3.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000. WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Zhang, Kobayashi, Yamamoto, Hayes: "The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence." in: The Journal of biological chemistry, Vol. 284, Issue 5, pp. 3195-210, (2009) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

  • Target

    NFE2L3 (Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3))

    Alternative Name

    NFE2L3

    Background

    This gene encodes a member of the cap 'n' collar basic-region leucine zipper family of transcription factors. The encoded protein heterodimerizes with small musculoaponeurotic fibrosarcoma factors to bind antioxidant response elements in target genes. This protein is a membrane bound glycoprotein that is targeted to the endoplasmic reticulum and the nuclear envelope. Pseudogenes of this gene are found on chromosomes 16, 17, and 18.

    Molecular Weight

    76154

    NCBI Accession

    NP_004280

    UniProt

    Q9Y4A8
You are here:
Chat with us!